Sociedad Española de Terapia Génica y Celular
  • Home
  • Policies & advocacy
    • Policies & advocacy
    • Regulatory information
      • GMP Guidelines
    • EMA guidance
    • ESGCT statements
    • Useful links
Home

This week in gene and cell therapy - 31 May 2019

Gene and cell therapy headlines 27 May - 31 May


Promethera Biosciences Announces First-Dosing in Phase 2a Clinical Study Evaluating World’s First Liver Stem Cell Therapy in Late-Stage NASH Patients?

Clinical Trial Underway for a Natural Killer Cell Therapy

First-line therapy with donor-derived HCMV-specific T cells reduces persistent HCMV infection by promoting antiviral immunity after allogenic stem cell transplantation

SALL3 expression balance underlies lineage biases in human induced pluripotent stem cell differentiation?

European Commission kills billion-euro flagship concept

Account login

Create a secure accountJoin
Forgotten your details?

Sponsors

Diamond

Platinum

Gold

Silver

Bronze

Copyright © 2023 Sociedad Española de Terapia Génica y Celular Member Area Terms and Conditions user account Privacy Policy Cookies Terms and Conditions membership purchase Terms and Conditions congress registration Terms and Conditions abstract submission Terms and Conditions user account RSS feed Join us Follow us